Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway

• Autorzy: Baronic K.B. , Mlinac K. , Petlevski R. , Ozretic D. , Vladic A. , Bognar S. K. , Zuntar I.
• Języki publikacji: EN

Abstrakty

EN

The impact of glutathione S-transferases (GSTs) detoxification pathway on complex pathogenesis and heterogeneity of clinical findings in multiple sclerosis (MS), particularly the exact correlation between indicators of clinical severity and different GST genotypes, has not yet been fully elucidated. The aim of the study was to assess the relationship between disability level in multiple sclerosis (estimated by Kurtzke Expanded Disability Status Scale), disease progression (estimated by Multiple Sclerosis Severity Score), the level of brain atrophy and lesion load (determined by MRI) and detoxification status (analyzing glutathione S-transferase P1, GSTP1, genotype profile), in a group of 58 MS patients and 68 age/gender- matched controls. The results present the first evidence on significantly higher frequency of GSTP1 C341T polymorphism (C-T transition) in healthy subjects compared to MS patients, suggesting it may act as a moderating factor in developing MS clinical phenotype. Gender-dependent distribution of the C341T polymorphism was found in both MS patients and controls, with higher frequency of C-T transition in females. In addition, preliminary data showed higher proportion of male MS patients with higher median MSSS scores, as well as lower brain atrophy level and lesion load in MS patients carrying the C341T mutation. Observed gender difference in distribution of the C341T polymorphism in MS patients, as well as in disease progression, suggests that GSTP1 detoxification pathway occurs in a gender-dependent manner and could therefore add to clinical severity in male MS patients.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2014
• Tom: 74
• Numer: 3
• Opis fizyczny: p.257-265,fig.,ref.

Twórcy

autor

Baronic K.B.

• Department of Neurology, Clinical Hospital “Sveti Duh”, Zagreb, Croatia

autor

Mlinac K.

• Department for Chemistry and Biochemistry and Croatian Inst. for Brain Research, School of Medicine, University of Zagreb, Zagreb, Croatia

autor

Petlevski R.

• Department for Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia

autor

Ozretic D.

• Department of Diagnostic and Interventional Radiology, University Hospital Centre Zagreb, Zagreb, Croatia

autor

Vladic A.

• Department of Neurology, Clinical Hospital “Sveti Duh”, Zagreb, Croatia

autor

Bognar S. K.

• Department for Chemistry and Biochemistry and Croatian Inst. for Brain Research, School of Medicine, University of Zagreb, Zagreb, Croatia

autor

Zuntar I.

• Department of Analytical Toxicology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia

Bibliografia

• Al NF, Strom M, Lindblom R, Aeinehband S, Bellander BM, Nyengaard JR, Lidman O, Piehl F (2013) Naturally occurring variation in the glutathione-s-transferase 4 gene determines neurodegeneration after traumatic brain inju¬ry. Antioxid Redox Signal 18: 784-794.
• Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J (1997) Molecular cloning, characterization, and expres¬sion in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272: 10004-10012.
• Armstrong RN (1997) Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10: 2-18.
• Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390: 191-214.
• Calabrese V, Raffaele R, Cosentino E, Rizza V (1994) Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. Int J Clin Pharmacol Res 14: 119-123.
• Dhib-Jalbut S, Arnold DL, Cleveland DW, Fisher M, Friedlander RM, Mouradian MM, Przedborski S, Trapp BD, Wyss-Coray T, Yong VW (2006) Neurodegeneration and neuroprotection in multiple sclerosis and other neuro¬degenerative diseases. J Neuroimmunol 176: 198-215.
• Fabrini R, Bocedi A, Massoud R, Federici G, Ricci G (2012) Spectrophotometric assay for serum glutathione transferase: a re-examination. Clin Biochem 45: 668-671.
• Habdous M, Vincent-Viry M, Visvikis S, Siest G (2002) Rapid spectrophotometric method for serum glutathione S-transferases activity. Clin Chim Acta 326: 131-142.
• Habdous M, Siest G, Herbeth B, Vincent-Viry M, Visvikis S (2004) Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological stud¬ies. Annales de Biologie Clinique 62: 15-24.
• Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, Wolf CR (1998) Pi-class glutathione S-transferase: regulation and function. Chem Biol Interact 111-112: 69-82.
• Kalincik T, Vivek V, Jokubaitis V, Lechner-Scott J, Trojano M, Izquierdo G, Lugaresi A, Grand'Maison F, Hupperts R, Oreja-Guevara C, Bergamaschi R, Iuliano G, Alroughani R, Van Pesch V, Amato MP, Slee M, Verheul F, Fernandez-Bolanos R, Fiol M, La Spitaleri D, Cristiano E, Gray O, Cabrera-Gomez JA, Shaygannejad V, Herbert J, Vucic S, Needham M, Petkovska-Boskova T, Sirbu CA, Duquette P, Girard M, Grammond P, Boz C, Giuliani G, Rio MA, Barnett M, Flechter S, Moore F, Singhal B, Bacile EA, Saladino ML, Shaw C, Skromne E, Poehlau D, Vella N, Spelman T, Liew D, Kilpatrick TJ, Butzkueven H (2013) Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain 136: 3609-3617.
• Kantarci OH, de Andrade M, Weinshenker BG (2002) Identifying disease modifying genes in multiple sclerosis. J Neuroimmunol 123: 144-159.
• Korpela H, Kinnunen E, Juntunen J, Kumpulainen J, Koskenvuo M (1989) Serum selenium concentration, glutathione peroxidase activity and lipid peroxides in a co-twin control study on multiple sclerosis. J Neurol Sci 91: 79-84.
• Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
• Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Bojanic V, Stokanovic D, Pavlovic D (2014) Glutathione homeostasis disruption of erythrocytes, but not glutathione peroxidase activity change, is closely accompanied with neurological and radiological scoring of acute CNS inflammation. Neuroimmunomodulation 21: 13-20.
• Mann CL, Davies MB, Boggild MD, Alldersea J, Fryer AA, Jones PW, Ko KC, Young C, Strange RC, Hawkins CP (2000) Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology 54: 552-557.
• McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121¬127.
• Migliore L, Coppede F (2002) Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 512: 135-153.
• Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
• Ortiz GG, Pacheco-Moisés FP, Bitzer-Quintero OK, Ramírez-Anguiano AC, Flores-Alvarado LJ, Ramírez- Ramírez V, Macias-Islas MA, Torres-Sánchez ED (2013) Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol 2013:708659 [doi: 10.1155/2013/708659]
• Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
• Powell T, Sussman JG, Davies-Jones GA (1992) MR imag¬ing in acute multiple sclerosis: ringlike appearance in plaques suggesting the presence of paramagnetic free radicals. AJNR Am J Neuroradiol 13: 1544-1546.
• Rovira A, León A (2008) MR in the diagnosis and monitor¬ing of multiple sclerosis: an overview. Eur J Radiol 67: 409-414.
• Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le PE, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sorensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sa M, Salemi G, Savettieri G, Hillert J, Compston DA (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease sever¬ity. Neurology 64:1144-1151.
• Sheehan D, Meade G, Foley GV, Dowd CA (2001) Structure, function and evolution of glutathione transferases: impli¬cations for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360: 1-16.
• Srinivasan R, Ratiney H, Hammond-Rosenbluth KE, Pelletier D, Nelson SJ (2010) MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. Magn Reson Imaging 28: 163-170.
• Stavropoulou C, Korakaki D, Rigana H, Voutsinas G, Polyzoi M, Georgakakos VN, Manola KN, Karageorgiou CE, Sambani C (2007) Glutathione-S-transferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: a pilot study. Eur J Neurol 14: 572-574.
• Tamura Y, Kataoka Y, Cui Y, Takamori Y, Watanabe Y, Yamada H (2007) Intracellular translocation of glutathi- one S-transferase pi during oligodendrocyte differentia¬tion in adult rat cerebral cortex in vivo. Neuroscience 148: 535-540.
• Tasset I, Aguera E, Sanchez-Lopez F, Feijoo M, Giraldo AI, Cruz AH, Gascon F, Tunez I (2012) Peripheral oxidative stress in relapsing-remitting multiple sclerosis. Clin Biochem 45: 440-444
• Tomassini V, Pozzilli C (2009) Sex hormones, brain damage and clinical course of Multiple Sclerosis. J Neurol Sci 286: 35-39
• Truyen L, van Waesberghe JH, van Walderveen MA, van Oosten BW, Polman CH, Hommes OR, Ader HJ, Barkhof F (1996) Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease pro¬gression in multiple sclerosis. Neurology 47: 1469-1476.
• University of Cambridge NUMSGG (2013) http://www. gene.cimr.cam.ac.uk/MSgenetics/GAMES/MSSS/
• Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA (1998) Human glutathione S-transferase P1 polymor¬phisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19: 275-280.
• Weatherby SJ, Mann CL, Davies MB, Fryer AA, Haq N, Strange RC, Hawkins CP (2000) A pilot study of the rela¬tionship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in mul¬tiple sclerosis. J Neurol 247: 467-470.
• Zivkovic M, Zivotic I, Dincic E, Stojkovic L, Vojinovic S, Stankovic A (2013) The glutathione S-transferase T1 deletion is associated with susceptibility to multiple scle¬rosis. J Neurol Sci 334: 6-9.
• Zuntar I, Kalanj-Bognar S, Topic E, Petlevski R, Stefanovic M, Demarin V (2004) The glutathione S-transferase poly-morphisms in a control population and in Alzheimer's disease patients. Clin Chem Lab Med 42:334-339